Avicanna
Advantage
Advanced Natural
Cannabinoid Solutions
A Leader in Biopharmaceutical Advancements with Natural Cannabinoids
Avicanna is a Canadian vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global market place.
Advanced R&D, pre-clinical and clinical platform
- 20+ scientists and clinicians housed in four federally licensed cannabinoid research laboratories
- Collaborations with world class academic and clinical institutions including the University of Toronto
- Optimized proprietary methodologies in breeding, cultivation, extraction, formulation development, clinical development and analytical testing over the past 4 years
Diversified and high margin income streams
- Comprehensive commercial portfolio and pipeline of products across consumer retail products, medical and pharmaceutical segments
- Multi-national operations and international sales from low-cost inputs to advanced finished products
- De-risked and diversified revenue streams ranging from seeds, genetics, cannabinoid API, bulk formulations, finished products and licensing of IP
World-class & low-cost vertical integration
- Two Colombian subsidiaries with a combined cultivation footprint of 480,000 sq. ft. and annual capacity of 30,000 kg of low-cost biomass and industrial extraction capacity
- Organic and sustainable cultivation practices with USDA National Organic Program certification ranked highest amongst global cannabis companies in the SAM Corporate Sustainability Assessment issued by S&P Global
Consumer Retail Products
Medical Products
Pharmaceutical Pipeline
Active Pharmaceutical Ingredients
Genetics and Seeds
